ARYx Therapeutics Inc
OTC:ARYX
ARYx Therapeutics Inc
OTC:ARYX
Price:
0.0005
USD
Market Closed
Market Cap:
$33.5
Cash Flow Statement
Cash Flow Statement
ARYx Therapeutics Inc
ARYx Therapeutics Inc
Currency: USD
| Mar-2007 | Jun-2007 | Sep-2007 | Dec-2007 | Mar-2008 | Jun-2008 | Sep-2008 | Dec-2008 | Mar-2009 | Jun-2009 | Sep-2009 | Dec-2009 | Mar-2010 | Jun-2010 | Sep-2010 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Net Income |
(32)
|
(21)
|
(24)
|
(28)
|
(32)
|
(37)
|
(26)
|
(31)
|
(32)
|
(29)
|
(40)
|
(33)
|
(30)
|
(24)
|
(18)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
1
|
1
|
1
|
1
|
2
|
2
|
1
|
2
|
1
|
1
|
2
|
2
|
0
|
1
|
1
|
|
| Other Non-Cash Items |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
1
|
|
| Cash Interest Paid |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Change in Working Capital |
20
|
17
|
(2)
|
(2)
|
(2)
|
(3)
|
(20)
|
(18)
|
(19)
|
(20)
|
(3)
|
(5)
|
(3)
|
(2)
|
(4)
|
|
| Cash from Operating Activities |
(10)
N/A
|
(2)
+79%
|
(24)
-984%
|
(28)
-17%
|
(31)
-14%
|
(37)
-16%
|
(43)
-16%
|
(45)
-6%
|
(47)
-4%
|
(45)
+4%
|
(40)
+12%
|
(35)
+12%
|
(30)
+15%
|
(23)
+23%
|
(20)
+12%
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
(1)
|
(1)
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
(14)
|
2
|
21
|
24
|
25
|
7
|
(3)
|
(2)
|
(9)
|
2
|
6
|
9
|
11
|
11
|
8
|
|
| Cash from Investing Activities |
(15)
N/A
|
1
N/A
|
20
+1 417%
|
23
+15%
|
24
+4%
|
6
-73%
|
(4)
N/A
|
(2)
+39%
|
(9)
-273%
|
2
N/A
|
6
+199%
|
8
+49%
|
11
+25%
|
11
+4%
|
8
-26%
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Common Stock |
30
|
0
|
0
|
44
|
44
|
44
|
44
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Net Issuance of Debt |
(2)
|
(2)
|
(2)
|
(3)
|
6
|
6
|
6
|
8
|
(1)
|
0
|
(1)
|
(3)
|
(4)
|
(6)
|
1
|
|
| Other |
0
|
0
|
(1)
|
0
|
(0)
|
0
|
1
|
20
|
20
|
20
|
20
|
(0)
|
6
|
6
|
6
|
|
| Cash from Financing Activities |
28
N/A
|
(2)
N/A
|
(3)
-33%
|
41
N/A
|
50
+22%
|
50
N/A
|
51
+1%
|
28
-44%
|
20
-30%
|
21
+4%
|
20
-3%
|
(2)
N/A
|
3
N/A
|
1
-55%
|
8
+492%
|
|
| Change in Cash | ||||||||||||||||
| Net Change in Cash |
3
N/A
|
(3)
N/A
|
(6)
-104%
|
37
N/A
|
43
+17%
|
20
-54%
|
4
-79%
|
(19)
N/A
|
(36)
-86%
|
(23)
+37%
|
(14)
+38%
|
(29)
-105%
|
(16)
+44%
|
(11)
+35%
|
(4)
+63%
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
(12)
N/A
|
(3)
+72%
|
(24)
-599%
|
(28)
-19%
|
(32)
-15%
|
(38)
-16%
|
(44)
-16%
|
(46)
-5%
|
(47)
-3%
|
(45)
+4%
|
(40)
+12%
|
(35)
+11%
|
(30)
+15%
|
(23)
+23%
|
(20)
+12%
|
|
Switch to:
Switch to:
See Also
Discover More
